FDA
-
-
-
-
-
-
-
Bayer to Present First Full FIND-CKD Results Investigating KERENDIA® (finerenone) in Non-Diabetic Chronic Kidney Disease at ERA 2026
-
-
-
-
-
-
-
FDA grants priority review for Bayer's HYRNUO lung cancer application
-
-
-
-
-
-
-
Bayer Alleges J&J’s Claims Regarding NUBEQA® are Deeply Flawed and Intentionally Aimed at Boosting Sales of J&J’s ERLEADA
-
-
-
-
-
-
-
Bayer Starts Phase IIa Study for Treatment of Patients With Alport Syndrome
-
-
-
-
-
-
-
Bayer receives FDA approval for Lynkuet menopause hot flash treatment
-
-
-
-
-
-
-
Judge Appoints Four Attorneys to Lead 77,000 Zantac Cancer Cases in Delaware
-
-
-
-
-
329,017 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

